Bobie Widders
Family Medicine · Conway, ARNPI 1114556370
Payments from drug & device makers
Across 332 payments — averaging $16.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$830
- AbbVie$773
- Novo Nordisk$571
- AstraZeneca$540
- Pfizer$484
- Lilly USA, LLC$300
- plus $2K from 30 others
What the payments were for
- Food & beverage$5,629100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 45 | $830 |
| AbbVie | 51 | $773 |
| Novo Nordisk | 40 | $571 |
| AstraZeneca | 14 | $540 |
| Pfizer | 35 | $484 |
| Lilly USA, LLC | 22 | $300 |
| Bayer | 14 | $231 |
| Phathom Pharmaceuticals, Inc. | 19 | $217 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $192 |
| Tris Pharma Inc | 7 | $131 |
| Shield Therapeutics Inc | 6 | $109 |
| Corium, LLC | 4 | $107 |
| Exact Sciences | 7 | $106 |
| Astellas Pharma US Inc | 5 | $100 |
| GSK | 6 | $92 |
| Boehringer Ingelheim | 5 | $91 |
| Corcept Therapeutics | 4 | $78 |
| Lundbeck LLC | 3 | $60 |
| Dexcom, Inc. | 3 | $56 |
| Almatica Pharma LLC | 3 | $55 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $52 |
| Collegium Pharmaceutical, Inc. | 3 | $50 |
| Antares Pharma, Inc. | 3 | $48 |
| Sanofi-aventis U.S. LLC | 2 | $45 |
| Noven Therapeutics, LLC | 3 | $43 |
| Boston Scientific | 1 | $37 |
| Johnson & Johnson | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Amgen | 2 | $31 |
| Alnylam Pharmaceuticals Inc. | 2 | $28 |
| Eisai Inc. | 1 | $21 |
| Mylan Specialty L.p. | 1 | $18 |
| Agios Pharmaceuticals, Inc. | 1 | $18 |
| Abbott | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,629 in reported general payments places this provider in the 85th percentile of 1,347 family medicine providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 52 | $66,614 |
| MounjaroTirzepatide | 52 | $55,262 |
| JardianceEmpagliflozin | 71 | $50,401 |
| FarxigaDapagliflozin Propanediol | 48 | $39,119 |
| TrulicityDulaglutide | 23 | $28,054 |
| JanuviaSitagliptin Phosphate | 27 | $24,550 |
| EliquisApixaban | 22 | $22,168 |
| XareltoRivaroxaban | 19 | $17,421 |
| Tresiba Flextouch U-200Insulin Degludec | 11 | $16,658 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 21 | $14,095 |
| TradjentaLinagliptin | 14 | $11,853 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $9,175 |
| MyrbetriqMirabegron | 11 | $7,108 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 14 | $6,752 |
| Tresiba Flextouch U-100Insulin Degludec | 12 | $6,168 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $300 | $83,31775 claims |
| Boehringer IngelheimJardiance, Tradjenta, Stiolto Respimat | $91 | $69,00699 claims |
| Novo NordiskOzempic | $571 | $66,61452 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $540 | $48,29560 claims |
| PfizerEliquis | $484 | $22,16822 claims |
| Johnson & JohnsonXarelto | $35 | $17,42119 claims |
| Astellas Pharma US IncMyrbetriq | $100 | $7,10811 claims |
| Sanofi-aventis U.S. LLCLantus | $45 | $1,91012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,347 family medicine providers in Arkansas.
Other family medicine in Conway
- Landon HumphreyConway$417K
- Thad HardinConway$19K
- David NaylorConway$17K
- Lander SmithConway$16K
- Randal BowlinConway$16K
- Joe CumminsConway$15K
- John DicksonConway$15K
- Michael CarsonConway$14K
- George KonisLittle Rock$26.6M
- Kevin RobertsLittle Rock$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.